Logo image of FN

FABRINET (FN) Stock Fundamental Analysis

NYSE:FN - New York Stock Exchange, Inc. - KYG3323L1005 - Common Stock - Currency: USD

177.14  +4.64 (+2.69%)

After market: 177.14 0 (0%)

Fundamental Rating

7

FN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the health and profitability get an excellent rating, making FN a very profitable company, without any liquidiy or solvency issues. FN is growing strongly while it is still valued neutral. This is a good combination! These ratings could make FN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year FN was profitable.
FN had a positive operating cash flow in the past year.
In the past 5 years FN has always been profitable.
FN had a positive operating cash flow in each of the past 5 years.
FN Yearly Net Income VS EBIT VS OCF VS FCFFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.82%, FN belongs to the top of the industry, outperforming 92.74% of the companies in the same industry.
FN has a Return On Equity of 17.69%. This is amongst the best in the industry. FN outperforms 87.90% of its industry peers.
FN has a better Return On Invested Capital (12.67%) than 87.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FN is above the industry average of 9.15%.
Industry RankSector Rank
ROA 12.82%
ROE 17.69%
ROIC 12.67%
ROA(3y)12.04%
ROA(5y)10.7%
ROE(3y)16.61%
ROE(5y)14.96%
ROIC(3y)12.81%
ROIC(5y)11.49%
FN Yearly ROA, ROE, ROICFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.44%, FN belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
In the last couple of years the Profit Margin of FN has grown nicely.
The Operating Margin of FN (9.65%) is better than 80.65% of its industry peers.
In the last couple of years the Operating Margin of FN has grown nicely.
FN has a Gross Margin of 12.27%. This is in the lower half of the industry: FN underperforms 74.19% of its industry peers.
FN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.65%
PM (TTM) 10.44%
GM 12.27%
OM growth 3Y6.27%
OM growth 5Y4.22%
PM growth 3Y9.19%
PM growth 5Y6.11%
GM growth 3Y1.59%
GM growth 5Y1.78%
FN Yearly Profit, Operating, Gross MarginsFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

9

2. Health

2.1 Basic Checks

FN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for FN remains at a similar level compared to 1 year ago.
The number of shares outstanding for FN has been reduced compared to 5 years ago.
FN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FN Yearly Shares OutstandingFN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
FN Yearly Total Debt VS Total AssetsFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

FN has an Altman-Z score of 8.71. This indicates that FN is financially healthy and has little risk of bankruptcy at the moment.
FN has a better Altman-Z score (8.71) than 90.32% of its industry peers.
There is no outstanding debt for FN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.71
ROIC/WACC1.41
WACC8.98%
FN Yearly LT Debt VS Equity VS FCFFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.32 indicates that FN has no problem at all paying its short term obligations.
FN has a Current ratio of 3.32. This is in the better half of the industry: FN outperforms 69.35% of its industry peers.
FN has a Quick Ratio of 2.58. This indicates that FN is financially healthy and has no problem in meeting its short term obligations.
FN has a better Quick ratio (2.58) than 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 2.58
FN Yearly Current Assets VS Current LiabilitesFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

FN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.37%, which is quite impressive.
FN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.44% yearly.
The Revenue has grown by 14.83% in the past year. This is quite good.
FN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.72% yearly.
EPS 1Y (TTM)24.37%
EPS 3Y23.89%
EPS 5Y18.44%
EPS Q2Q%25.48%
Revenue 1Y (TTM)14.83%
Revenue growth 3Y15.33%
Revenue growth 5Y12.72%
Sales Q2Q%16.97%

3.2 Future

The Earnings Per Share is expected to grow by 16.20% on average over the next years. This is quite good.
Based on estimates for the next years, FN will show a quite strong growth in Revenue. The Revenue will grow by 15.63% on average per year.
EPS Next Y18.44%
EPS Next 2Y15.72%
EPS Next 3Y16.2%
EPS Next 5YN/A
Revenue Next Year18.05%
Revenue Next 2Y15.52%
Revenue Next 3Y15.63%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FN Yearly Revenue VS EstimatesFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
FN Yearly EPS VS EstimatesFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.08, which indicates a rather expensive current valuation of FN.
FN's Price/Earnings ratio is a bit cheaper when compared to the industry. FN is cheaper than 74.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.63, FN is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 14.90, the valuation of FN can be described as correct.
FN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FN is cheaper than 76.61% of the companies in the same industry.
FN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.08
Fwd PE 14.9
FN Price Earnings VS Forward Price EarningsFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

63.71% of the companies in the same industry are more expensive than FN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FN indicates a somewhat cheap valuation: FN is cheaper than 70.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.21
EV/EBITDA 13.4
FN Per share dataFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

FN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of FN may justify a higher PE ratio.
A more expensive valuation may be justified as FN's earnings are expected to grow with 16.20% in the coming years.
PEG (NY)0.98
PEG (5Y)0.98
EPS Next 2Y15.72%
EPS Next 3Y16.2%

0

5. Dividend

5.1 Amount

FN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FABRINET

NYSE:FN (4/22/2025, 4:15:00 PM)

After market: 177.14 0 (0%)

177.14

+4.64 (+2.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners106.36%
Inst Owner Change-0.29%
Ins Owners0.28%
Ins Owner Change0.17%
Market Cap6.35B
Analysts77.5
Price Target276.57 (56.13%)
Short Float %5.77%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.57%
Min EPS beat(2)-2.55%
Max EPS beat(2)1.4%
EPS beat(4)3
Avg EPS beat(4)3.25%
Min EPS beat(4)-2.55%
Max EPS beat(4)9.92%
EPS beat(8)6
Avg EPS beat(8)2.19%
EPS beat(12)8
Avg EPS beat(12)2.31%
EPS beat(16)11
Avg EPS beat(16)2.55%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-0.2%
Revenue beat(12)3
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)2.71%
PT rev (3m)2.59%
EPS NQ rev (1m)-2.62%
EPS NQ rev (3m)-0.62%
EPS NY rev (1m)-0.97%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)4.09%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)1.93%
Valuation
Industry RankSector Rank
PE 18.08
Fwd PE 14.9
P/S 2.03
P/FCF 20.21
P/OCF 16.57
P/B 3.44
P/tB 3.45
EV/EBITDA 13.4
EPS(TTM)9.8
EY5.53%
EPS(NY)11.89
Fwd EY6.71%
FCF(TTM)8.76
FCFY4.95%
OCF(TTM)10.69
OCFY6.03%
SpS87.15
BVpS51.44
TBVpS51.38
PEG (NY)0.98
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 12.82%
ROE 17.69%
ROCE 16.03%
ROIC 12.67%
ROICexc 25.2%
ROICexgc 25.25%
OM 9.65%
PM (TTM) 10.44%
GM 12.27%
FCFM 10.05%
ROA(3y)12.04%
ROA(5y)10.7%
ROE(3y)16.61%
ROE(5y)14.96%
ROIC(3y)12.81%
ROIC(5y)11.49%
ROICexc(3y)21.7%
ROICexc(5y)20.16%
ROICexgc(3y)21.77%
ROICexgc(5y)20.26%
ROCE(3y)16.21%
ROCE(5y)14.55%
ROICexcg growth 3Y7.43%
ROICexcg growth 5Y3.89%
ROICexc growth 3Y7.59%
ROICexc growth 5Y4.15%
OM growth 3Y6.27%
OM growth 5Y4.22%
PM growth 3Y9.19%
PM growth 5Y6.11%
GM growth 3Y1.59%
GM growth 5Y1.78%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 136.37%
Cap/Sales 2.21%
Interest Coverage 250
Cash Conversion 108.84%
Profit Quality 96.31%
Current Ratio 3.32
Quick Ratio 2.58
Altman-Z 8.71
F-Score6
WACC8.98%
ROIC/WACC1.41
Cap/Depr(3y)158.37%
Cap/Depr(5y)147.7%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)66.94%
Profit Quality(5y)69.06%
High Growth Momentum
Growth
EPS 1Y (TTM)24.37%
EPS 3Y23.89%
EPS 5Y18.44%
EPS Q2Q%25.48%
EPS Next Y18.44%
EPS Next 2Y15.72%
EPS Next 3Y16.2%
EPS Next 5YN/A
Revenue 1Y (TTM)14.83%
Revenue growth 3Y15.33%
Revenue growth 5Y12.72%
Sales Q2Q%16.97%
Revenue Next Year18.05%
Revenue Next 2Y15.52%
Revenue Next 3Y15.63%
Revenue Next 5YN/A
EBIT growth 1Y14.51%
EBIT growth 3Y22.56%
EBIT growth 5Y17.47%
EBIT Next Year37.25%
EBIT Next 3Y22.94%
EBIT Next 5YN/A
FCF growth 1Y187%
FCF growth 3Y70.03%
FCF growth 5Y23.2%
OCF growth 1Y123.07%
OCF growth 3Y51.55%
OCF growth 5Y22.89%